Determining the Optimal Dose of Tenecteplase Before Endovascular Therapy for Ischaemic Stroke (EXTEND-IA TNK Part 2)
Clinical trial NCT03340493 · COMPLETED
Trial details
- NCT number
- NCT03340493
- Sponsor
- Neuroscience Trials Australia
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-06
- Primary completion
- 2019-07-23
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.